Hi [[ session.user.profile.firstName ]]
Sort by:
    • Understanding & Treating Generalized Anxiety Disorder Understanding & Treating Generalized Anxiety Disorder Mark Pollack, MD, Director, Center for Anxiety and Traumatic Stress Disorders, Massachusetts General Hospital Recorded: Sep 21 2010 7:00 pm UTC 77 mins
    • Attendees will:
      - discuss the neurobiology of GAD
      - recognize symptoms and diagnose individuals with generalized anxiety disorder
      - plan evidence-based treatment for individuals with GAD and gad and comorbid disorders including depression, sleep disorders, cardiac illnesses and IBS.

      Webinar speaker:
      Mark Pollack, MD, Director, Center for Anxiety and Traumatic Stress Disorders, Massachusetts General Hospital
      Professor of Psychiatry, Harvard Medical School

      Dr. Pollack’s areas of clinical and research interest include the acute and long-term course, pathophysiology, and treatment of patients with anxiety disorders and associated comorbidities, development of novel pharmacologic agents for mood and anxiety disorders, uses of combined cognitive-behavioral and pharmacologic therapies for treatment refractory patients, presentation and treatment of anxiety in the medical setting, and the pathophysiology and treatment of substance abuse.

      Blackwell Futura Media Services designates this educational activity for 1 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity. Blackwell Futura Media Services is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. DETAILS at: http://bit.ly/ADAA_CME1

      Read more >
    • GAD and Cormorbidity:  Impact on Patient Health GAD and Cormorbidity: Impact on Patient Health Dr. Naomi M. Simon, Associate Director of the Center for Anxiety and Traumatic Stress Disorders Recorded: Nov 9 2010 5:00 pm UTC 66 mins
    • Generalized Anxiety Disorder (GAD) is common, chronic, and associated with substantial impairment in function and quality of life. GAD commonly occurs comorbid with mood disorders and anxiety disorders. GAD comorbidity has been clearly linked to additive worsening of outcomes and function in both Major Depressive Disorder and in Bipolar Disorder. This presentation will provide an update on current understandings about the incidence and nature of GAD and comorbid disorders, and their impact on patient health.

      During this webinar attendees will:

      1) Understand the overlap of Generalized Anxiety Disorder (GAD) with mood disorders

      2) Understand the impact of GAD comorbidity on severity of illness including suicidality, quality of life and functioning in individuals with GAD

      3) Learn about the need to address GAD and its comorbidities to optimally improve patient health

      Naomi Michele Simon, M.D., M.Sc.

      Dr. Naomi M. Simon is Associate Director of the Center for Anxiety and Traumatic Stress Disorders and Director of the recently established Complicated Grief Program at Massachusetts General Hospital, and is Associate Professor of Psychiatry, Harvard Medical School.

      Blackwell Futura Media Services designates this educational activity for 1 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity. Blackwell Futura Media Services is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. DETAILS at: http://bit.ly/ADAA_CME5

      Read more >